希腊COVID-19措施降级期间2022年8月流感传播:需持续整合呼吸道病毒监测的证据
在COVID-19大流行前两年流感及其他呼吸道病毒几乎消失后,2022年8月初希腊三个岛屿检测到以甲型H3N2为主的流感活动增加。33例有呼吸道症状且SARS-CoV-2快速抗原检测阴性者中,24例流感阳性(20例A(H3N2)亚型,4例A(H1N1)pdm09亚型)。系统发育分析显示所选样本属于包含2022/23疫苗株的亚分支簇。数据提示流感可在另一种高传染性病原体(如SARS-CoV-2)存在下传播,作者建议将季节性监测转为持续监测。
要点
- 2022年8月初希腊三岛33例SARS-CoV-2抗原检测阴性呼吸道症状者中24例流感阳性。
- 24例流感阳性中20例为A(H3N2)亚型,4例为A(H1N1)pdm09亚型。
- 作者建议从季节性监测转向持续监测,尤其在游客多的地区。
核心结论
- 数据提示流感可在另一种高传染性病原体(如SARS-CoV-2)存在下传播,两者传播方式相似。
- 作者强调需改进当前流感监测,建议从季节性监测转向持续监测,尤其在游客数量多的地区。
- 全年监测可使疫苗接种活动和抗病毒药物采购过程更及时启动。
研究设计与样本
- 对2022年8月初希腊三个岛屿33例有呼吸道症状且SARS-CoV-2快速抗原检测阴性者进行检测。
- 对两种亚型的部分样本进行系统发育分析。
主要发现
- 33例中24例流感阳性:20例为A(H3N2)亚型,4例为A(H1N1)pdm09亚型。
- 所选样本的系统发育分析显示其落入包含2022/23疫苗株的亚分支簇内。
临床怎么用
- 作者建议从季节性监测转向持续监测,尤其在游客数量多的地区。
- 作者认为全年监测可使疫苗接种活动和抗病毒药物采购过程更及时启动。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
After the near absence of influenza and other respiratory viruses during the first 2 years of the COVID-19 pandemic, an increased activity of mainly influenza A(H3N2) was detected at the beginning of August 2022 in Greece on three islands. Of 33 cases with respiratory symptoms testing negative for SARS-CoV-2 with rapid antigen tests, 24 were positive for influenza: 20 as A(H3N2) subtype and four as A(H1N1)pdm09 subtype. Phylogenetic analysis of selected samples from both subtypes was performed and they fell into clusters within subclades that included the 2022/23 vaccine strains. Our data suggest that influenza can be transmitted even in the presence of another highly infectious pathogen, such as SARS-CoV-2, with a similar transmission mode. We highlight the need for implementing changes in the current influenza surveillance and suggest a move from seasonal to continuous surveillance, especially in areas with a high number of tourists. Year-round surveillance would allow for a timelier start of vaccination campaigns and antiviral drugs procurement processes.
引用
- Mellou K, Tryfinopoulou K, Emmanouil M, et al. Influenza transmission during COVID-19 measures downscaling in Greece, August 2022: evidence for the need of continuous integrated surveillance of respiratory viruses. Euro Surveill. 2023. PMID: 37440348. doi:10.2807/1560-7917.ES.2023.28.28.2200754
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。